Unknown

Dataset Information

0

Structure of the Bacillus anthracis dTDP-L-rhamnose-biosynthetic enzyme dTDP-4-dehydrorhamnose 3,5-epimerase (RfbC).


ABSTRACT: The exosporium layer of Bacillus anthracis spores is rich in L-rhamnose, a common bacterial cell-wall component, which often contributes to the virulence of pathogens by increasing their adherence and immune evasion. The biosynthetic pathway used to form the activated L-rhamnose donor dTDP-L-rhamnose consists of four enzymes (RfbA, RfbB, RfbC and RfbD) and is an attractive drug target because there are no homologs in mammals. It was found that co-purifying and screening RfbC (dTDP-6-deoxy-D-xylo-4-hexulose 3,5-epimerase) from B. anthracis in the presence of the other three B. anthracis enzymes of the biosynthetic pathway yielded crystals that were suitable for data collection. RfbC crystallized as a dimer and its structure was determined at 1.63?Å resolution. Two different ligands were bound in the protein structure: pyrophosphate in the active site of one monomer and dTDP in the other monomer. A structural comparison with RfbC homologs showed that the key active-site residues are conserved across kingdoms.

SUBMITTER: Shornikov A 

PROVIDER: S-EPMC5713671 | biostudies-literature | 2017 Dec

REPOSITORIES: biostudies-literature

altmetric image

Publications

Structure of the Bacillus anthracis dTDP-L-rhamnose-biosynthetic enzyme dTDP-4-dehydrorhamnose 3,5-epimerase (RfbC).

Shornikov Aleksander A   Tran Ha H   Macias Jennifer J   Halavaty Andrei S AS   Minasov George G   Anderson Wayne F WF   Kuhn Misty L ML  

Acta crystallographica. Section F, Structural biology communications 20171110 Pt 12


The exosporium layer of Bacillus anthracis spores is rich in L-rhamnose, a common bacterial cell-wall component, which often contributes to the virulence of pathogens by increasing their adherence and immune evasion. The biosynthetic pathway used to form the activated L-rhamnose donor dTDP-L-rhamnose consists of four enzymes (RfbA, RfbB, RfbC and RfbD) and is an attractive drug target because there are no homologs in mammals. It was found that co-purifying and screening RfbC (dTDP-6-deoxy-D-xylo  ...[more]

Similar Datasets

| S-EPMC5713668 | biostudies-literature
| S-EPMC5864537 | biostudies-literature
| S-EPMC5683032 | biostudies-literature
| S-EPMC3147701 | biostudies-literature
| S-EPMC8606822 | biostudies-literature
| S-EPMC2782033 | biostudies-literature
| S-EPMC4888466 | biostudies-literature
| S-EPMC90481 | biostudies-literature
| S-EPMC4022621 | biostudies-literature
| S-EPMC6487966 | biostudies-literature